1
Clinical Trials associated with Cryopreserved human umbilical cord(TissueTech, Inc.)A Phase 2, 52-Week Trial of TTAX03 vs. Saline as a Single Intra-articular Injection in Kellgren-Lawrence Grade 3-4 Knee OA
It is hypothesized that a single Intra-articular Injection of TTAX03, 100mg in 2mL of saline, will have more benefit with respect to the proportion of responders 12 weeks post-injection than an equal volume of saline, based on the OMERACT-OARSI responder criteria.
100 Clinical Results associated with Cryopreserved human umbilical cord(TissueTech, Inc.)
100 Translational Medicine associated with Cryopreserved human umbilical cord(TissueTech, Inc.)
100 Patents (Medical) associated with Cryopreserved human umbilical cord(TissueTech, Inc.)
100 Deals associated with Cryopreserved human umbilical cord(TissueTech, Inc.)